In vitro and in vivo activity of melaleuca alternifolia mixed with tissue conditioner on Candida albicans

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 105, Issue 3, 2008, Pages 327-332

  Catalán, Alfonso ^a   Pacheco, Juan G ^b   Martínez, Alejandra ^b   Mondaca, Maria A ^b  

^a Department of Restorative Dentistry   (Chile)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID RESIN; ANTIFUNGAL AGENT; COE COMFORT; NYSTATIN; PHTHALIC ACID DERIVATIVE; TEA TREE OIL; UNCLASSIFIED DRUG;

AGED; ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; MALE; MELALEUCA; MICROBIOLOGY; MIDDLE AGED; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REPARATIVE DENTISTRY; STOMATITIS; THRUSH;

ACRYLIC RESINS; AGED; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; COLONY COUNT, MICROBIAL; DENTURE, COMPLETE; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MELALEUCA; MIDDLE AGED; NYSTATIN; PHTHALIC ACIDS; PHYTOTHERAPY; STOMATITIS, DENTURE; TEA TREE OIL; TISSUE CONDITIONING (DENTAL);

EID: 38949116324     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.08.025     Document Type: Article

References (39)

1. Budtz-Jorgensen E. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol 10 (1981) 65-80
2. Budtz-Jörgensen E. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol Scand 48 (1990) 61-69
3. Wilson J. The aetiology, diagnosis and management of denture stomatitis. Br Dent J 185 (1998) 380-384
4. Bergendal T., and Isaacson G. A combined, clinical, mycological and histological study of the denture stomatitis. Acta Odontol Scand 41 (1983) 33-44
5. Newton A.V. Denture sore mouth: a possible aetiology. Br Dent J 112 (1962) 357-360
6. Darwazeh A.M., Al-Refai S., and Al-Mojaiwel S. Isolation of Candida species from the oral cavity and fingertips of complete denture wearers. J Prosthet Dent 86 (2001) 420-423
7. Frank R.M., and Steuer P. Transmission electron microscopy of plaque accumulations in denture stomatitis. J Prosthet Dent 53 (1985) 115-124
8. Catalán A., Herrera R., and Martínez A. Denture plaque and palatal mucosa in denture stomatitis: scanning electron microscopic and microbiologic study. J Prosthet Dent 57 (1987) 581-586
9. Catalán A. Stomatitis associated with wearing removable dentures: etiology and treatment. Cah Prothese 12 (1984) 59-78
10. Espinoza I., Rojas R., Aranda W., and Gamonal J. Prevalence of oral mucosal lesions in elderly people in Santiago, Chile. J Oral Pathol Med 32 (2003) 571-575
11. Kulak Y., Arikan A., and Kazazoglu E. Existence of Candida albicans and microorganisms in denture stomatitis patients. J Oral Rehabil 24 (1997) 788-790
12. Monsenego P. Presence of microorganisms on the fitting denture complete surface: study in vivo. J Oral Rehabil 27 (2000) 708-713
13. Barbeu J., Seguin J., Goulet J.P., Koninck L., Avon S.L., Lalonde B., et al. Reassessing the presence of Candida albicans in denture-related stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 51-59
14. Bisell V., Felix D.H., and Wray D. Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis. Oral Surg Oral Med Oral Pathol 76 (1993) 35-39
15. Davenport J.C., Basker M., Heath J.R., Ralph J.P., Glantz P.O., and Hammond P. Initial prosthetic treatment. Br Dent J 190 (2001) 235-244
16. Kulak Y., and Kazazoglu E. In vivo and in vitro study of fungal presence and growth on three tissue conditioning materials on implant supported complete denture wearers. J Oral Rehabil 25 (1998) 135-138
17. Thomas C.J., and Nutt G.M. The in vitro fungicidal properties of Visco-gel, alone and combined with nystatin and amphotericin B. J Oral Rehabil 5 (1978) 167-172
18. Truhlar M.R., Shay K., and Sohnle P. Use of a new technique for quantification of antifungal activity of nystatin incorporated in denture liners. J Prosthet Dent 71 (1994) 517-524
19. Quin D.M. The effectiveness in vitro of Miconazole and Ketoconazole combined with tissue conditioners in inhibiting the growth of Candida albicans. J Oral Rehabil 12 (1985) 177-182
20. Barnabé W., De Mendonca Neto T., Pimenta F.C., Pegoraro L.F., and Scolaro J.M. Efficacy of sodium hypochlorite and coconut soap used as disinfecting agents in the reduction of denture stomatitis, Streptococcus mutans and Candida albicans. J Oral Rehabil 31 (2004) 453-459
21. Dixon D.L., Breeding L.C., and Faler T.A. Microwave disinfection of denture base materials colonized with Candida albicans. J Prosthet Dent 81 (1999) 207-214
22. Brand C., Grimbaldeston M.A., Gamble J.R., Drew J., Finlay-Jones J.J., and Hart P.H. Tea tree oil reduces the swelling associated with the efferent phase of contact hypersensitivity response. Inflamm Res 5 (2002) 236-244
23. Koh K.J., Pearce A.L., Marshman G., Finlay-Jones J.J., and Hart P.H. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol 147 6 (2002) 1212-1217
24. Jandourek A., Vaishampayan J.K., and Vasquez J.A. Efficacy of Melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 12 (1998) 1033-1037
25. D′Auria F.D., Laino S., Strippoli V., Tecca M., Salvatore G., Batinelli L., et al. In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J Chemother 13 (2001) 377-383
26. Hammer K.A., Carson C.F., and Riley T.V. In vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 42 (1998) 591-595
27. Carson C.F., Cookson B.D., Farrelly H.D., and Riley T.V. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 35 (1995) 421-424
28. Hammer K.A., Carson C.F., and Riley T.V. In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 50 (2002) 195-199
29. Hammer K.A., Carson C.F., and Riley T.V. In vitro activities of Ketoconazole, Econazole, Miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob Agents Chemother 44 (2000) 467-469
30. Carson C.F., and Riley T.V. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J Appl Bacteriol 78 (1995) 264-269
31. Cox S.D., Mann C.M., Markham J.L., Bell H.C., Gustafson J.E., Warmington R., et al. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 88 (2000) 170-175
32. Hammer K.A., Carson C.F., and Riley T.V. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med Mycol 38 (2000) 170-175
33. Vasquez J.A., and Zawawi A.A. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin Trials 3 (2002) 379-385
34. Hammer K.A., Carson C.F., and Riley T.V. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 53 (2004) 1081-1085
35. Syed S.A., and Loesche W.J. Survival of human dental plaque flora in various transport media. Appl Microbiol 24 (1972) 638-644
36. Honing Larone D. Medically important fungi. A guide to identification. 4th ed. (2002), ASM Press, Washington, DC 307-335
37. Graham B.S., Jones D.W., and Sutow E.J. Clinical implications of resilient lining material research. Part II: gelation and flow properties of tissue conditioners. J Prosthet Dent 65 (1991) 413-418
38. Kawano F., Tada N., Nagao K., and Matsumoto N. The influence of soft living material on pressure distribution. J Prosthet Dent 65 (1991) 567-575
39. Waters M., Williams D.W., Jagger R.G., and Lewis M.A.O. Adherence of Candida albicans to experimental denture soft lining materials. J Prosthet Dent 77 (1997) 306-312